Skip to main content
Figure 3 | Journal of Experimental & Clinical Cancer Research

Figure 3

From: Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma

Figure 3

hMOF is downregulated in different pathological diagnosis of human kidney cancer. A. Relative mRNA expression levels of hMOF in different type of kidney cancer. Total RNA was isolated from four paired pathological diagnosed ccRCC, chRCC, paRCC, unclassified RCC, respectively and matched normal/adjacent kidney tissues. Relative mRNA expression levels of hMOF and CA9 were analyzed by qRT-PCR. Error bars represent the standard error of the mean of 3 independent experiments. B. Log2 ratio of hMOF and CA9 mRNA expression in four different types of human kidney cancer. Ratio of mRNA expression is displayed as a ratio of expression of hMOF or CA9 gene in ccRCC versus matched normal tissues. C. Analysis of werstern blotting. Equivalent total protein amount of whole cell extracts from four different pathological diagnosed kidney cancers (ccRCC, chRCC, paRCC and unRCC) and its corresponding normal/adjacent tissues were subjected to SDS-PAGE in 12% gels, and proteins were detected by western blotting with indicated antibodies. D. Summarization of hMOF and CA9 expression in RCC. Total cases of ccRCC (21) include four initial selected ccRCC (data not shown), sixteen additional ccRCC and one case used in comparing experiment.

Back to article page